Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Z Squared (COEP) Cash & Equivalents (2020 - 2025)

Z Squared has reported Cash & Equivalents over the past 6 years, most recently at $5.7 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 964.83% year-over-year to $5.7 million; the TTM value through Dec 2025 reached $5.7 million, up 964.83%, while the annual FY2025 figure was $5.7 million, 964.83% up from the prior year.
  • Cash & Equivalents for Q4 2025 was $5.7 million at Z Squared, up from $4.9 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $7.4 million in Q3 2022 and troughed at $532885.0 in Q4 2024.
  • A 5-year average of $2.5 million and a median of $2.1 million in 2023 define the central range for Cash & Equivalents.
  • Biggest five-year swings in Cash & Equivalents: soared 1160.77% in 2022 and later tumbled 80.85% in 2023.
  • Year by year, Cash & Equivalents stood at $2.2 million in 2021, then soared by 73.95% to $3.8 million in 2022, then plummeted by 61.25% to $1.5 million in 2023, then plummeted by 63.73% to $532885.0 in 2024, then surged by 964.83% to $5.7 million in 2025.
  • Business Quant data shows Cash & Equivalents for COEP at $5.7 million in Q4 2025, $4.9 million in Q3 2025, and $2.0 million in Q2 2025.